Literature DB >> 6383502

Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult.

J Bahous, A Cartier, L Pineau, C Bernard, H Ghezzo, R R Martin, J L Malo.   

Abstract

Fifty adults with chronic bronchiectasis (mean duration since diagnosis: 25 +/- 16.4 years), excluding those cases secondary to tuberculosis or hypogammaglobulinemia, were investigated by a questionnaire, a chest radiograph and lung function tests. Of these, 29 with an FEV1 greater than 1.5 1 underwent methacholine inhalation tests. Fourty-three subjects and three subjects respectively showed an obstructive or a mixed obstructive and restrictive defect, only four having normal lung function tests. Sixty-nine percent of subjects tested had a provocative concentration of methacholine causing a 20% fall in FEV1 (PC20) less than 16 mg X ml-1. Subjects with daily sputum production had lower values of FEV1 and FEV1/forced vital capacity (FVC) compared to subjects with less than daily sputum. Subjects with clinical features of bronchial hyperexcitability had significantly lower baseline FEV1, vital capacity, and maximal mid-expiratory flow rate (FEF25-75). Subjects with lower PC20 values had significantly lower baseline FEV1, FEV1/FVC and FEF25-75. Finally, subjects with the greatest extent of radiological abnormalities had lower baseline FEV1, FEV1/FVC and diffusing capacity, and a higher residual volume. We conclude that chronic bronchiectasis is associated with significant changes in lung function tests and increased responsiveness to methacholine in the majority of affected individuals.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383502

Source DB:  PubMed          Journal:  Bull Eur Physiopathol Respir        ISSN: 0395-3890


  10 in total

1.  Nebulisers for bronchiectasis.

Authors:  D C Currie
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study.

Authors:  J Pang; H S Chan; J Y Sung
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

3.  Analysis of factors associated with bronchial hyperreactivity to methacholine in bronchiectasis.

Authors:  M Ip; W K Lam; S Y So; E Liong; C Y Chan; K M Tse
Journal:  Lung       Date:  1991       Impact factor: 2.584

Review 4.  Clinical implications of airway hyperresponsiveness in COPD.

Authors:  Nicola Scichilone; Salvatore Battaglia; Alba La Sala; Vincenzo Bellia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

5.  HRCT score in bronchiectasis: correlation with pulmonary function tests and pulmonary artery pressure.

Authors:  Abdullaziz H Alzeer
Journal:  Ann Thorac Med       Date:  2008-07       Impact factor: 2.219

Review 6.  Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?

Authors:  Paul King
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  The effects of bronchiectasis on asthma exacerbation.

Authors:  Hye Ran Kang; Gyu-Sik Choi; Sun Jin Park; Yoon Kyung Song; Jeong Min Kim; Junghoon Ha; Yung Hee Lee; Byoung Hoon Lee; Sang-Hoon Kim; Jae Hyung Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-11-28

8.  A review of 151 cases of pediatric noncystic fibrosis bronchiectasis in a tertiary care center.

Authors:  Hanaa Hasan Banjar
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

9.  Relationships between high-resolution computed tomography, lung function and bacteriology in stable bronchiectasis.

Authors:  Jin-Hwa Lee; Yoo-Kyung Kim; Hyon-Ju Kwag; Jung-Hyun Chang
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

10.  Effect of obstructive airway disease in patients with non-cystic fibrosis bronchiectasis.

Authors:  Mohammed Khalid; Sarfraz Saleemi; Mohammed Zeitouni; Saleh Al Dammas; Muhammad Rehan Khaliq
Journal:  Ann Saudi Med       Date:  2004 Jul-Aug       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.